YAVAPFMC
MRNA icon

Yahav Achim Ve Achayot - Provident Funds Management Company’s Moderna MRNA Stock Holding History

Yahav Achim Ve Achayot - Provident Funds Management Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,700
Closed -$576K – 50
2023
Q2 		$576K Hold
4,700
– – 0.44% 46
2023
Q1 		$693K Buy
+4,700
New +$775K 0.68% 50

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Yahav Achim Ve Achayot - Provident Funds Management Company's MRNA Position: Q3 2023 in Review

Yahav Achim Ve Achayot - Provident Funds Management Company sold out of Moderna (MRNA) in Q3 2023, closing a stake of 4,700 shares — an estimated $576K sold.

Yahav Achim Ve Achayot - Provident Funds Management Company first reported a position in MRNA in Q1 2023 and held it in 2 quarters. The position peaked at $693K in Q1 2023. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Yahav Achim Ve Achayot - Provident Funds Management Company reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Yahav Achim Ve Achayot - Provident Funds Management Company sold 4,700 Moderna shares in Q3 2023, an estimated $576K.
  • Yahav Achim Ve Achayot - Provident Funds Management Company first reported a position in Moderna in Q1 2023 and held it in 2 quarters.
  • Yahav Achim Ve Achayot - Provident Funds Management Company's Moderna position peaked at $693K in Q1 2023.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Yahav Achim Ve Achayot - Provident Funds Management Company's 13F filing for Q3 2023, filed 25 Oct 2023.